Phoebe A. Cohen, Ph.D. - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 
Area:
Paleobiology, Paleobotany

12/139 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Hoffman PF, Abbot DS, Ashkenazy Y, Benn DI, Brocks JJ, Cohen PA, Cox GM, Creveling JR, Donnadieu Y, Erwin DH, Fairchild IJ, Ferreira D, Goodman JC, Halverson GP, Jansen MF, et al. Snowball Earth climate dynamics and Cryogenian geology-geobiology. Science Advances. 3: e1600983. PMID 29134193 DOI: 10.1126/sciadv.1600983  0.32
2015 Cohen PA, Macdonald FA. The Proterozoic Record of Eukaryotes Paleobiology. 41: 610-632. DOI: 10.1017/pab.2015.25  1
2012 Wilson JP, Grotzinger JP, Fischer WW, Hand KP, Jensen S, Knoll AH, Abelson J, Metz JM, McLoughlin N, Cohen PA, Tice MM. Deep-water incised valley deposits at the Ediacaran-Cambrian boundary in southern Namibia contain abundant Treptichnus pedum Palaios. 27: 252-273. DOI: 10.2110/palo.2011.p11-036r  1
2012 Cohen PA, Knoll AH. Scale microfossils from the mid-neoproterozoic fifteenmile group, Yukon Territory Journal of Paleontology. 86: 775-800. DOI: 10.1666/11-138.1  1
2011 Macdonald FA, Cohen PA. The Tatonduk inlier, Alaska-Yukon border Geological Society Memoir. 36: 389-396. DOI: 10.1144/M36.35  1
2011 Cohen PA, Schopf JW, Butterfield NJ, Kudryavtsev AB, Macdonald FA. Phosphate biomineralization in mid-neoproterozoic protists Geology. 39: 539-542. DOI: 10.1130/G31833.1  1
2010 Macdonald FA, Schmitz MD, Crowley JL, Roots CF, Jones DS, Maloof AC, Strauss JV, Cohen PA, Johnston DT, Schrag DP. Calibrating the Cryogenian. Science (New York, N.Y.). 327: 1241-3. PMID 20203045 DOI: 10.1126/science.1183325  1
2010 Macdonald FA, Cohen PA, Dudás FO, Schrag DP. Early neoproterozoic scale microfossils in the Lower Tindir Group of Alaska and the Yukon Territory Geology. 38: 143-146. DOI: 10.1130/G25637.1  1
2009 Cohen PA, Knoll AH, Kodner RB. Large spinose microfossils in Ediacaran rocks as resting stages of early animals. Proceedings of the National Academy of Sciences of the United States of America. 106: 6519-24. PMID 19366668 DOI: 10.1073/pnas.0902322106  1
2009 Cohen PA, Bradley A, Knoll AH, Grotzinger JP, Jensen S, Abelson J, Hand K, Love G, Metz J, McLoughlin N, Meister P, Shepard R, Tice M, Wilson JP. Tubular compression fossils from the ediacaran nama group, namibia Journal of Paleontology. 83: 110-122. DOI: 10.1666/09-040R.1  1
2008 Allmon WD, Cohen PA. Palaeoecological significance of turritelline gastropod-dominated assemblages from the mid-Cretaceous (Albian-Cenomanian) of Texas and Oklahoma, USA Cretaceous Research. 29: 65-77. DOI: 10.1016/j.cretres.2007.04.001  1
2006 Knoll AH, Javaux EJ, Hewitt D, Cohen P. Eukaryotic organisms in Proterozoic oceans. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 361: 1023-38. PMID 16754612 DOI: 10.1098/rstb.2006.1843  1
Low-probability matches
2020 Liljestrand FL, Knoll AH, Tosca NJ, Cohen PA, Macdonald FA, Peng Y, Johnston DT. The triple oxygen isotope composition of Precambrian chert Earth and Planetary Science Letters. 537: 116167. DOI: 10.1016/j.epsl.2020.116167  0.04
2017 Cohen PA, Strauss JV, Rooney AD, Sharma M, Tosca N. Controlled hydroxyapatite biomineralization in an ~810 million-year-old unicellular eukaryote. Science Advances. 3: e1700095. PMID 28782008 DOI: 10.1126/sciadv.1700095  0.04
2016 Lakshminarayanan V, Supekar NT, Wei J, McCurry DB, Dueck AC, Kosiorek HE, Trivedi PP, Bradley JM, Madsen CS, Pathangey LB, Hoelzinger DB, Wolfert MA, Boons GJ, Cohen PA, Gendler SJ. MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice. Plos One. 11: e0145920. PMID 26788922 DOI: 10.1371/journal.pone.0145920  0.04
2015 Thompson P, Lakshminarayanan V, Supekar NT, Bradley JM, Cohen PA, Wolfert MA, Gendler SJ, Boons GJ. Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide. Chemical Communications (Cambridge, England). 51: 10214-7. PMID 26022217 DOI: 10.1039/c5cc02199e  0.04
2014 Hoelzinger DB, Dominguez AL, Cohen PA, Gendler SJ. Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges. Cancer Research. 74: 6845-55. PMID 25297635 DOI: 10.1158/0008-5472.CAN-14-0836  0.04
2014 Abdel-Aal AB, Lakshminarayanan V, Thompson P, Supekar N, Bradley JM, Wolfert MA, Cohen PA, Gendler SJ, Boons GJ. Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist. Chembiochem : a European Journal of Chemical Biology. 15: 1508-13. PMID 24890740 DOI: 10.1002/cbic.201402077  0.04
2014 Northfelt DW, Ramanathan RK, Cohen PA, Von Hoff DD, Weiss GJ, Dietsch GN, Manjarrez KL, Randall TD, Hershberg RM. A phase I dose-finding study of the novel Toll-like receptor 8 agonist VTX-2337 in adult subjects with advanced solid tumors or lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3683-91. PMID 24807889 DOI: 10.1158/1078-0432.CCR-14-0392  0.04
2014 Chodon T, Comin-Anduix B, Chmielowski B, Koya RC, Wu Z, Auerbach M, Ng C, Avramis E, Seja E, Villanueva A, McCannel TA, Ishiyama A, Czernin J, Radu CG, Wang X, ... ... Cohen PA, et al. Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2457-65. PMID 24634374 DOI: 10.1158/1078-0432.CCR-13-3017  0.04
2014 Jaini R, Rayman P, Cohen PA, Finke JH, Tuohy VK. Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy. International Journal of Cancer. Journal International Du Cancer. 134: 1695-705. PMID 24105638 DOI: 10.1002/ijc.28488  0.04
2013 Poh TW, Madsen CS, Gorman JE, Marler RJ, Leighton JA, Cohen PA, Gendler SJ. Downregulation of hematopoietic MUC1 during experimental colitis increases tumor-promoting myeloid-derived suppressor cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5039-52. PMID 23873692 DOI: 10.1158/1078-0432.CCR-13-0278  0.04
2013 Finke JH, Rayman PA, Ko JS, Bradley JM, Gendler SJ, Cohen PA. Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics. Cancer Journal (Sudbury, Mass.). 19: 353-64. PMID 23867518 DOI: 10.1097/PPO.0b013e31829da0ae  0.04
2013 Paustian C, Taylor P, Johnson T, Xu M, Ramirez N, Rosenthal KS, Shu S, Cohen PA, Czerniecki BJ, Koski GK. Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17. Plos One. 8: e54804. PMID 23382974 DOI: 10.1371/journal.pone.0054804  0.04
2013 Kottschade LA, Suman VJ, Perez DG, McWilliams RR, Kaur JS, Amatruda TT, Geoffroy FJ, Gross HM, Cohen PA, Jaslowski AJ, Kosel ML, Markovic SN. A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775. Cancer. 119: 586-92. PMID 22915053 DOI: 10.1002/cncr.27760  0.04
2012 Cohen PA, Ko JS, Storkus WJ, Spencer CD, Bradley JM, Gorman JE, McCurry DB, Zorro-Manrique S, Dominguez AL, Pathangey LB, Rayman PA, Rini BI, Gendler SJ, Finke JH. Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape. Immunological Investigations. 41: 680-710. PMID 23017141 DOI: 10.3109/08820139.2012.703745  0.04
2012 Zhao X, Bose A, Komita H, Taylor JL, Chi N, Lowe DB, Okada H, Cao Y, Mukhopadhyay D, Cohen PA, Storkus WJ. Vaccines targeting tumor blood vessel antigens promote CD8(+) T cell-dependent tumor eradication or dormancy in HLA-A2 transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 188: 1782-8. PMID 22246626 DOI: 10.4049/jimmunol.1101644  0.04
2012 Lakshminarayanan V, Thompson P, Wolfert MA, Buskas T, Bradley JM, Pathangey LB, Madsen CS, Cohen PA, Gendler SJ, Boons GJ. Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine. Proceedings of the National Academy of Sciences of the United States of America. 109: 261-6. PMID 22171012 DOI: 10.1073/pnas.1115166109  0.04
2011 Bose A, Taylor JL, Alber S, Watkins SC, Garcia JA, Rini BI, Ko JS, Cohen PA, Finke JH, Storkus WJ. Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination. International Journal of Cancer. Journal International Du Cancer. 129: 2158-70. PMID 21170961 DOI: 10.1002/ijc.25863  0.04
2011 Paustian C, Caspell R, Johnson T, Cohen PA, Shu S, Xu S, Czerniecki BJ, Koski GK. Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells. Human Immunology. 72: 24-31. PMID 20951755 DOI: 10.1016/j.humimm.2010.10.004  0.04
2010 Taylor PR, Koski GK, Paustian CC, Bailey E, Cohen PA, Moore FB, Zimmerman DH, Rosenthal KS. J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells. Vaccine. 28: 5533-42. PMID 20600501 DOI: 10.1016/j.vaccine.2010.06.043  0.04
2010 Ko JS, Rayman P, Ireland J, Swaidani S, Li G, Bunting KD, Rini B, Finke JH, Cohen PA. Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained. Cancer Research. 70: 3526-36. PMID 20406969 DOI: 10.1158/0008-5472.CAN-09-3278  0.04
2010 Cho EI, Tan C, Koski GK, Cohen PA, Shu S, Lee WT. Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines. Head & Neck. 32: 700-7. PMID 19908319 DOI: 10.1002/hed.21241  0.04
2008 Watanabe S, Deguchi K, Zheng R, Tamai H, Wang LX, Cohen PA, Shu S. Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. Journal of Immunology (Baltimore, Md. : 1950). 181: 3291-300. PMID 18714001  0.04
2008 Cohen PA, Koski GK, Czerniecki BJ, Bunting KD, Fu XY, Wang Z, Zhang WJ, Carter CS, Awad M, Distel CA, Nagem H, Paustian CC, Johnson TD, Tisdale JF, Shu S. STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells. Blood. 112: 1832-43. PMID 18577706 DOI: 10.1182/blood-2007-12-130138  0.04
2008 Zheng R, Cohen PA, Paustian CA, Johnson TD, Lee WT, Shu S, Koski GK. Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12. Cancer Research. 68: 4045-9. PMID 18519662 DOI: 10.1158/0008-5472.CAN-07-6669  0.04
2008 Koski GK, Cohen PA, Roses RE, Xu S, Czerniecki BJ. Reengineering dendritic cell-based anti-cancer vaccines. Immunological Reviews. 222: 256-76. PMID 18364007 DOI: 10.1111/j.1600-065X.2008.00617.x  0.04
2008 Tamai H, Watanabe S, Zheng R, Deguchi K, Cohen PA, Koski GK, Shu S. Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells. Clinical Immunology (Orlando, Fla.). 127: 66-77. PMID 18262845 DOI: 10.1016/j.clim.2007.12.001  0.04
2007 Storkus WJ, Herrem C, Kawabe M, Cohen PA, Bukowski RM, Finke JH, Wesa AK. Improving immunotherapy by conditionally enhancing MHC class I presentation of tumor antigen-derived Peptide epitopes. Critical Reviews in Immunology. 27: 485-93. PMID 18197809  0.04
2007 Shu S, Zheng R, Lee WT, Cohen PA. Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy. Critical Reviews in Immunology. 27: 463-83. PMID 18197808  0.04
2007 Zheng R, Kjaergaard J, Lee WT, Cohen PA, Shu S. Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapy. Cancer Treatment and Research. 135: 223-37. PMID 17953420  0.04
2007 Czerniecki BJ, Koski GK, Koldovsky U, Xu S, Cohen PA, Mick R, Nisenbaum H, Pasha T, Xu M, Fox KR, Weinstein S, Orel SG, Vonderheide R, Coukos G, DeMichele A, et al. Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Research. 67: 1842-52. PMID 17293384 DOI: 10.1158/0008-5472.CAN-06-4038  0.04
2006 Kuriyama H, Watanabe S, Kjaergaard J, Tamai H, Zheng R, Weinberg AD, Hu HM, Cohen PA, Plautz GE, Shu S. Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination. Cellular Immunology. 243: 30-40. PMID 17207783 DOI: 10.1016/j.cellimm.2006.11.002  0.04
2004 Kuriyama H, Shimizu K, Lee W, Kjaergaard J, Parkhurst MR, Cohen PA, Shu S. Therapeutic vaccine generated by electrofusion of dendritic cells and tumour cells. Developments in Biologicals. 116: 169-78; discussion 1. PMID 15603192  0.04
2004 Wang LX, Huang WX, Graor H, Cohen PA, Kim JA, Shu S, Plautz GE. Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells. Journal of Translational Medicine. 2: 41. PMID 15566571 DOI: 10.1186/1479-5876-2-41  0.04
2004 Koski GK, Karikó K, Xu S, Weissman D, Cohen PA, Czerniecki BJ. Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 172: 3989-93. PMID 15034009  0.04
2004 Wang LX, Kjaergaard J, Cohen PA, Shu S, Plautz GE. Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapy. Journal of Immunology (Baltimore, Md. : 1950). 172: 3462-8. PMID 15004146  0.04
2003 Bedrosian I, Mick R, Xu S, Nisenbaum H, Faries M, Zhang P, Cohen PA, Koski G, Czerniecki BJ. Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 3826-35. PMID 14551301 DOI: 10.1200/JCO.2003.04.042  0.04
2003 Plautz GE, Cohen PA, Shu S. Considerations on clinical use of T cell immunotherapy for cancer. Archivum Immunologiae Et Therapiae Experimentalis. 51: 245-57. PMID 12956434  0.04
2003 Xu S, Koski GK, Faries M, Bedrosian I, Mick R, Maeurer M, Cheever MA, Cohen PA, Czerniecki BJ. Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism Journal of Immunology. 171: 2251-2261. PMID 12928369  0.04
2003 Kjaergaard J, Peng L, Cohen PA, Shu S. Therapeutic efficacy of adoptive immunotherapy is predicated on in vivo antigen-specific proliferation of donor T cells Clinical Immunology. 108: 8-20. PMID 12865066 DOI: 10.1016/S1521-6616(03)00090-1  0.04
2002 Peng L, Kjaergäard J, Plautz GE, Awad M, Drazba JA, Shu S, Cohen PA. Tumor-induced L-selectinhigh suppressor T cells mediate potent effector T cell blockade and cause failure of otherwise curative adoptive immunotherapy. Journal of Immunology (Baltimore, Md. : 1950). 169: 4811-21. PMID 12391191  0.04
2002 Hayashi T, Tanaka H, Tanaka J, Wang R, Averbook BJ, Cohen PA, Shu S. Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusion Clinical Immunology. 104: 14-20. PMID 12139943 DOI: 10.1006/clim.2002.5224  0.04
2002 Lyakh LA, Koski GK, Young HA, Spence SE, Cohen PA, Rice NR. Adenovirus type 5 vectors induce dendritic cell differentiation in human CD14(+) monocytes cultured under serum-free conditions. Blood. 99: 600-8. PMID 11781244 DOI: 10.1182/blood.V99.2.600  0.04
2001 Kjaergaard J, Peng L, Cohen PA, Drazba JA, Weinberg AD, Shu S. Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor. Journal of Immunology (Baltimore, Md. : 1950). 167: 6669-77. PMID 11714839  0.04
2001 Shu S, Cohen PA. Mechanism of tumor eradication by transfer of sensitized T cells European Journal of Cancer. 37: S27.  0.04
2018 Cohen PA, Riedman LA. It's a protist-eat-protist world: recalcitrance, predation, and evolution in the Tonian-Cryogenian ocean. Emerging Topics in Life Sciences. 2: 173-180. PMID 32412620 DOI: 10.1042/ETLS20170145  0.01
2018 Cohen PA, Riedman LA. Correction: It's a protist-eat-protist world: recalcitrance, predation, and evolution in the Tonian-Cryogenian ocean. Emerging Topics in Life Sciences. 2: 325-326. PMID 32412607 DOI: 10.1042/ETLS-2017-0145C_COR  0.01
2016 Tucker PE, Bulsara MK, Salfinger SG, Tan JJ, Green H, Cohen PA. The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy. Maturitas. 85: 42-8. PMID 26857878 DOI: 10.1016/j.maturitas.2015.12.004  0.01
2016 Acton JN, Salfinger SG, Tan J, Cohen PA. Outcomes of Total Laparoscopic Hysterectomy Using a 5 mm vs. 10 mm Laparoscope: A Randomized Control Trial Obstetrical and Gynecological Survey. 71: 17-18. DOI: 10.1097/OGX.0000000000000278  0.01
2015 Goh J, Mohan GR, Ladwa R, Ananda S, Cohen PA, Baron-Hay S. Frontline treatment of epithelial ovarian cancer. Asia-Pacific Journal of Clinical Oncology. 11: 1-16. PMID 26669253 DOI: 10.1111/ajco.12449  0.01
2015 Munro A, Powell RG, Cohen P, Bowen S, Spilsbury K, O'Leary P, Semmens JB, Codde J, Williams V, Steel N, Leung Y. Spontaneous regression of CIN2 in women aged 18-24 years: a retrospective study of a state-wide population in Western Australia. Acta Obstetricia Et Gynecologica Scandinavica. PMID 26660398 DOI: 10.1111/aogs.12835  0.01
2015 Tucker PE, Bulsara MK, Salfinger SG, Tan JJ, Green H, Cohen PA. Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy. Gynecologic Oncology. PMID 26545955 DOI: 10.1016/j.ygyno.2015.11.002  0.01
2015 Hochman M, Cohen PA. Reconsidering Guidelines on the Use of Pneumococcal Vaccines in Adults 65 Years or Older. Jama Internal Medicine. 1-2. PMID 26502317 DOI: 10.1001/jamainternmed.2015.5689  0.01
2015 Cohen PA. Vinpocetine: An Unapproved Drug Sold as a Dietary Supplement. Mayo Clinic Proceedings. 90: 1455. PMID 26434971 DOI: 10.1016/j.mayocp.2015.07.008  0.01
2015 Cohen PA, Donini CF, Nguyen NT, Lincet H, Vendrell JA. The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value. Oncotarget. PMID 26431164 DOI: 10.18632/oncotarget.5893  0.01
2015 Avula B, Chittiboyina AG, Sagi S, Wang YH, Wang M, Khan IA, Cohen PA. Identification and quantification of vinpocetine and picamilon in dietary supplements sold in the United States. Drug Testing and Analysis. PMID 26426301 DOI: 10.1002/dta.1853  0.01
2015 Cohen PA, Wang YH, Maller G, DeSouza R, Khan IA. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Testing and Analysis. PMID 26391406 DOI: 10.1002/dta.1849  0.01
2015 Acton JN, Salfinger SG, Tan J, Cohen PA. Outcomes of total laparoscopic hysterectomy using a 5mm vs. 10mm laparoscope: A randomized control trial. Journal of Minimally Invasive Gynecology. PMID 26371370 DOI: 10.1016/j.jmig.2015.09.001  0.01
2015 Tan A, Stewart CJ, Garrett KL, Rye M, Cohen PA. Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii. Endocrine Pathology. PMID 26362194 DOI: 10.1007/s12022-015-9394-3  0.01
2015 Avula B, Wang M, Sagi S, Cohen PA, Wang YH, Lasonkar P, Chittiboyina A, Feng W, Khan IA. Identification and quantification of 1,3-dimethylbutylamine (DMBA) from Camellia sinensis tea leaves and dietary supplements. Journal of Pharmaceutical and Biomedical Analysis. 115: 159-168. PMID 26209774 DOI: 10.1016/j.jpba.2015.07.004  0.01
2015 Brame GR, Cohen PA, Norberto JJ. Acute mitral valve regurgitation after acute coronary syndrome. Jaapa : Official Journal of the American Academy of Physician Assistants. 28: 43-4. PMID 26208015 DOI: 10.1097/01.JAA.0000469438.90443.2b  0.01
2015 Dietsch GN, Randall TD, Gottardo R, Northfelt DW, Ramanathan RK, Cohen PA, Manjarrez KL, Newkirk M, Bryan JK, Hershberg RM. Late Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152744 DOI: 10.1158/1078-0432.CCR-15-0578  0.01
2015 Tucker PE, Cohen PA, Tan J, Tan J. Conversion of a gastric band into an intraperitoneal port in a patient with optimally debulked stage 3C serous ovarian carcinoma. Gynecologic Oncology Reports. 12: 75-6. PMID 26076165 DOI: 10.1016/j.gore.2015.03.008  0.01
2015 Cohen PA, Zeijlon R, Nardin R, Keizers PH, Venhuis B. Hemorrhagic Stroke Probably Caused by Exercise Combined With a Sports Supplement Containing β-Methylphenyl-ethylamine (BMPEA): A Case Report. Annals of Internal Medicine. 162: 879-80. PMID 26075771 DOI: 10.7326/L15-5101  0.01
2015 Rapoport AB, McCormick D, Cohen PA. Screening for Schistosoma mansoni and Strongyloides stercoralis Infection Among Brazilian Immigrants in the United States. Open Forum Infectious Diseases. 2: ofv003. PMID 26034754 DOI: 10.1093/ofid/ofv003  0.01
2015 Shepherd AR, Hoh IM, Goh EH, Cohen PA, Steele D. Aggressive renal tumour: squamous cell carcinoma with sarcomatoid differentiation. Anz Journal of Surgery. PMID 25962888 DOI: 10.1111/ans.13155  0.01
2015 Cohen PA, Zeijlon R, Nardin R, Keizers PH, Venhuis B. Hemorrhagic Stroke Probably Caused by Exercise Combined With a Sports Supplement Containing β-Methylphenylethylamine (BMPEA): A Case Report. Annals of Internal Medicine. PMID 25962129 DOI: 10.7326/L15-0106  0.01
2015 Cohen PA, Bloszies C, Yee C, Gerona R. An amphetamine isomer whose efficacy and safety in humans has never been studied, β-methylphenylethylamine (BMPEA), is found in multiple dietary supplements. Drug Testing and Analysis. PMID 25847603 DOI: 10.1002/dta.1793  0.01
2015 Vilquin P, Donini CF, Villedieu M, Grisard E, Corbo L, Bachelot T, Vendrell JA, Cohen PA. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer. Breast Cancer Research : Bcr. 17: 13. PMID 25633049 DOI: 10.1186/s13058-015-0515-1  0.01
2015 Kelly JJ, Perugini RA, Wang QL, Czerniach DR, Flahive J, Cohen PA. The presence of Helicobacter pylori is not associated with long-term anastomotic complications in gastric bypass patients. Surgical Endoscopy. PMID 25552229 DOI: 10.1007/s00464-014-4022-8  0.01
2015 Cohen PA, Travis JC, Venhuis BJ. A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements. Drug Testing and Analysis. 7: 83-7. PMID 25293509 DOI: 10.1002/dta.1735  0.01
2015 Cohen PA, Zeijlon R, Nardin R, Keizers PHJ, Venhuis B. Hemorrhagic stroke probably caused by exercise combined with a sports supplement containing-methylphenylethylamine (BMPEA): A case report Annals of Internal Medicine. 162: 879-880. DOI: 10.7326/L155101  0.01
2015 Shepherd ARH, Hoh IMY, Goh EH, Cohen PA, Steele D. Aggressive renal tumour: Squamous cell carcinoma with sarcomatoid differentiation Anz Journal of Surgery. DOI: 10.1111/ans.13155  0.01
2014 Cohen PA, Maller G, DeSouza R, Neal-Kababick J. Presence of banned drugs in dietary supplements following FDA recalls. Jama. 312: 1691-3. PMID 25335153 DOI: 10.1001/jama.2014.10308  0.01
2014 Avula B, Cohen PA, Wang YH, Sagi S, Feng W, Wang M, Zweigenbaum J, Shuangcheng M, Khan IA. Chemical profiling and quantification of monacolins and citrinin in red yeast rice commercial raw materials and dietary supplements using liquid chromatography-accurate QToF mass spectrometry: Chemometrics application. Journal of Pharmaceutical and Biomedical Analysis. 100: 243-53. PMID 25168220 DOI: 10.1016/j.jpba.2014.07.039  0.01
2014 Nguyen NT, Vendrell JA, Poulard C, Gy?rffy B, Goddard-Léon S, Bièche I, Corbo L, Le Romancer M, Bachelot T, Treilleux I, Cohen PA. A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancers. Molecular Oncology. 8: 1441-57. PMID 24973012 DOI: 10.1016/j.molonc.2014.05.013  0.01
2014 Cohen PA. Hazards of hindsight--monitoring the safety of nutritional supplements. The New England Journal of Medicine. 370: 1277-80. PMID 24693886 DOI: 10.1056/NEJMp1315559  0.01
2014 Rosario R, Cohen PA, Shelling AN. The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours. Gynecologic Oncology. 133: 382-7. PMID 24342437 DOI: 10.1016/j.ygyno.2013.12.012  0.01
2014 Cohen PA, Travis JC, Venhuis BJ. A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Testing and Analysis. 6: 805-7. PMID 24124092 DOI: 10.1002/dta.1578  0.01
2013 Guen VJ, Gamble C, Flajolet M, Unger S, Thollet A, Ferandin Y, Superti-Furga A, Cohen PA, Meijer L, Colas P. CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome. Proceedings of the National Academy of Sciences of the United States of America. 110: 19525-30. PMID 24218572 DOI: 10.1073/pnas.1306814110  0.01
2013 Rosario R, Wilson M, Cheng WT, Payne K, Cohen PA, Fong P, Shelling AN. Adult granulosa cell tumours (GCT): clinicopathological outcomes including FOXL2 mutational status and expression. Gynecologic Oncology. 131: 325-9. PMID 24007948 DOI: 10.1016/j.ygyno.2013.08.031  0.01
2013 Cohen PA, Venhuis BJ. Adulterated sexual enhancement supplements: more than mojo. Jama Internal Medicine. 173: 1169-70. PMID 23699734 DOI: 10.1001/jamainternmed.2013.854  0.01
2013 Cohen PA. DMAA as a dietary ingredient-reply. Jama Internal Medicine. 173: 595. PMID 23568632 DOI: 10.1001/jamainternmed.2013.3776  0.01
2013 Vilquin P, Villedieu M, Grisard E, Ben Larbi S, Ghayad SE, Heudel PE, Bachelot T, Corbo L, Treilleux I, Vendrell JA, Cohen PA. Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor. International Journal of Cancer. Journal International Du Cancer. 133: 1589-602. PMID 23553037 DOI: 10.1002/ijc.28182  0.01
2013 Prestat E, de Morais SR, Vendrell JA, Thollet A, Gautier C, Cohen PA, Aussem A. Learning the local Bayesian network structure around the ZNF217 oncogene in breast tumours. Computers in Biology and Medicine. 43: 334-41. PMID 23375235 DOI: 10.1016/j.compbiomed.2012.12.002  0.01
2013 Cohen PA, Attipoe S, Travis J, Stevens M, Deuster P. Caffeine content of dietary supplements consumed on military bases. Jama Internal Medicine. 173: 592-4; discussion 59. PMID 23303430 DOI: 10.1001/jamainternmed.2013.3254  0.01
2013 Cohen PA. Peter Hessler: Teacher, archaeologist, anthropologist, travel writer, master storyteller Journal of Asian Studies. 72: 251-272. DOI: 10.1017/S0021911812002197  0.01
2012 De Carvalho LM, Cohen PA, Silva CV, Moreira AP, Falcão TM, Dal Molin TR, Zemolin G, Martini M. A new approach to determining pharmacologic adulteration of herbal weight loss products. Food Additives & Contaminants. Part a, Chemistry, Analysis, Control, Exposure & Risk Assessment. 29: 1661-7. PMID 22849359 DOI: 10.1080/19440049.2012.706834  0.01
2012 Cohen PA, Goday A, Swann JP. The return of rainbow diet pills. American Journal of Public Health. 102: 1676-86. PMID 22813089 DOI: 10.2105/AJPH.2012.300655  0.01
2012 Vendrell JA, Thollet A, Nguyen NT, Ghayad SE, Vinot S, Bièche I, Grisard E, Josserand V, Coll JL, Roux P, Corbo L, Treilleux I, Rimokh R, Cohen PA. ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion. Cancer Research. 72: 3593-606. PMID 22593193 DOI: 10.1158/0008-5472.CAN-11-3095  0.01
2012 Cohen PA. DMAA as a dietary supplement ingredient. Archives of Internal Medicine. 172: 1038-9. PMID 22566490 DOI: 10.1001/archinternmed.2012.1677  0.01
2012 Cohen PA. Coronary artery calcium scanning and conflicts of interest. Archives of Internal Medicine. 172: 670; author reply 67. PMID 22529238 DOI: 10.1001/archinternmed.2012.276  0.01
2012 Cohen PA. Assessing supplement safety--the FDA's controversial proposal. The New England Journal of Medicine. 366: 389-91. PMID 22276780 DOI: 10.1056/NEJMp1113325  0.01
2012 Cohen PA. A false sense of security? The U.S. Food and Drug Administration's framework for evaluating new supplement ingredients. Antioxidants & Redox Signaling. 16: 458-60. PMID 22040067 DOI: 10.1089/ars.2011.4376  0.01
2012 Cohen PA, Benner C, McCormick D. Use of a pharmaceutically adulterated dietary supplement, Pai You Guo, among Brazilian-born women in the United States. Journal of General Internal Medicine. 27: 51-6. PMID 21845487 DOI: 10.1007/s11606-011-1828-0  0.01
2011 Cohen PA. Phentermine plus topiramate in the treatment of obesity. Lancet (London, England). 378: 126; author reply 12. PMID 21742168 DOI: 10.1016/S0140-6736(11)61081-7  0.01
2011 Givon L, Porter S, Padmanabhan B, Goren J, Cohen PA. Levetiracetam, seizures, and suicidality. Harvard Review of Psychiatry. 19: 47-55. PMID 21250896 DOI: 10.3109/10673229.2011.549777  0.01
2010 Thollet A, Vendrell JA, Payen L, Ghayad SE, Ben Larbi S, Grisard E, Collins C, Villedieu M, Cohen PA. ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells. Molecular Cancer. 9: 291. PMID 21059223 DOI: 10.1186/1476-4598-9-291  0.01
2010 Cohen PA, Ernst E. Safety of herbal supplements: a guide for cardiologists. Cardiovascular Therapeutics. 28: 246-53. PMID 20633025 DOI: 10.1111/j.1755-5922.2010.00193.x  0.01
2010 Ricciardelli C, Bianco-Miotto T, Jindal S, Dodd TJ, Cohen PA, Marshall VR, Sutherland PD, Samaratunga H, Kench JG, Dong Y, Wang H, Clements JA, Risbridger GP, Sutherland RL, Tilley WD, et al. Comparative biomarker expression and RNA integrity in biospecimens derived from radical retropubic and robot-assisted laparoscopic prostatectomies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1755-65. PMID 20615888 DOI: 10.1158/1055-9965.EPI-10-0059  0.01
2010 Smith BR, Cohen PA. Dependence on the Brazilian diet pill: a case report. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 19: 291-2. PMID 20525038 DOI: 10.1111/j.1521-0391.2010.00034.x  0.01
2010 Hsiang MS, Carlton EJ, Zhang Y, Zhong B, Dongchuan Q, Cohen PA, Stewart CC, Spear RC. Use of ultrasonography to evaluate Schistosoma japonicum-related morbidity in children, Sichuan Province, China, 2000-2007. The American Journal of Tropical Medicine and Hygiene. 82: 103-11. PMID 20065003 DOI: 10.4269/ajtmh.2010.09-0061  0.01
2010 Ghayad SE, Cohen PA. Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients. Recent Patents On Anti-Cancer Drug Discovery. 5: 29-57. PMID 19751211 DOI: 10.2174/157489210789702208  0.01
2010 Ghayad SE, Vendrell JA, Ben Larbi S, Dumontet C, Bieche I, Cohen PA. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways. International Journal of Cancer. Journal International Du Cancer. 126: 545-62. PMID 19609946 DOI: 10.1002/ijc.24750  0.01
2009 Cohen PA. American roulette--contaminated dietary supplements. The New England Journal of Medicine. 361: 1523-5. PMID 19812394 DOI: 10.1056/NEJMp0904768  0.01
2009 Tang PH, Cohen PA. Primary neuroblastoma of the mandible. Singapore Medical Journal. 50: e5-7. PMID 19224073  0.01
2009 Cohen PA, Tedesco LA. Willing, ready, and able? How we must exercise leadership for needed change in dental education. Journal of Dental Education. 73: 3-11. PMID 19126763  0.01
2009 Cohen PA. Imported fenproporex-based diet pills from Brazil: a report of two cases. Journal of General Internal Medicine. 24: 430-3. PMID 19096898 DOI: 10.1007/s11606-008-0878-4  0.01
2009 Ghayad SE, Vendrell JA, Bieche I, Spyratos F, Dumontet C, Treilleux I, Lidereau R, Cohen PA. Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer. Journal of Molecular Endocrinology. 42: 87-103. PMID 18984771 DOI: 10.1677/JME-08-0076  0.01
2009 Cohen PA, McCormick D, Casey C, Dawson GF, Hacker KA. Imported compounded diet pill use among Brazilian women immigrants in the United States. Journal of Immigrant and Minority Health / Center For Minority Public Health. 11: 229-36. PMID 18066718 DOI: 10.1007/s10903-007-9099-x  0.01
2008 Ghayad SE, Bieche I, Vendrell JA, Keime C, Lidereau R, Dumontet C, Cohen PA. mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels. Cancer Science. 99: 1992-2003. PMID 19016759 DOI: 10.1111/j.1349-7006.2008.00955.x  0.01
2008 Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA. A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Breast Cancer Research : Bcr. 10: R88. PMID 18928543 DOI: 10.1186/bcr2158  0.01
2007 Cohen PA, Gower AC, Stucchi AF, Leeman SE, Becker JM, Reed KL. A neurokinin-1 receptor antagonist that reduces intraabdominal adhesion formation increases peritoneal matrix metalloproteinase activity. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 15: 800-8. PMID 18028127 DOI: 10.1111/j.1524-475X.2007.00291.x  0.01
2007 Heydrick SJ, Reed KL, Cohen PA, Aarons CB, Gower AC, Becker JM, Stucchi AF. Intraperitoneal administration of methylene blue attenuates oxidative stress, increases peritoneal fibrinolysis, and inhibits intraabdominal adhesion formation. The Journal of Surgical Research. 143: 311-9. PMID 17826794 DOI: 10.1016/j.jss.2006.11.012  0.01
2007 Cohen PA, Aarons CB, Gower AC, Stucchi AF, Leeman SE, Becker JM, Reed KL. The effectiveness of a single intraperitoneal infusion of a neurokinin-1 receptor antagonist in reducing postoperative adhesion formation is time dependent. Surgery. 141: 368-75. PMID 17349849 DOI: 10.1016/j.surg.2006.09.007  0.01
2007 Turner MS, Cohen PA, Finn OJ. Lack of effective MUC1 tumor antigen-specific immunity in MUC1-transgenic mice results from a Th/T regulatory cell imbalance that can be corrected by adoptive transfer of wild-type Th cells. Journal of Immunology (Baltimore, Md. : 1950). 178: 2787-93. PMID 17312122  0.01
2007 Vendrell JA, Ghayad S, Ben-Larbi S, Dumontet C, Mechti N, Cohen PA. A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. Oncogene. 26: 4656-67. PMID 17297453 DOI: 10.1038/sj.onc.1210269  0.01
2007 Aarons CB, Cohen PA, Gower A, Reed KL, Leeman SE, Stucchi AF, Becker JM. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Annals of Surgery. 245: 176-84. PMID 17245169 DOI: 10.1097/01.sla.0000236627.07927.7c  0.01
2006 Cohen PA. The red hat. Academic Medicine : Journal of the Association of American Medical Colleges. 81: 644. PMID 16799287 DOI: 10.1097/00001888-200607000-00010  0.01
2005 Ferey S, Kalifa G, Cohen PA, Adamsbaum C. [Imaging of pediatric spine injury]. Journal De Radiologie. 86: 263-72. PMID 15798640  0.01
2005 Vendrell JA, Bieche I, Desmetz C, Badia E, Tozlu S, Nguyen C, Nicolas JC, Lidereau R, Cohen PA. Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines. Endocrine-Related Cancer. 12: 75-92. PMID 15788640 DOI: 10.1677/erc.1.00899  0.01
2004 Vendrell JA, Magnino F, Danis E, Duchesne MJ, Pinloche S, Pons M, Birnbaum D, Nguyen C, Theillet C, Cohen PA. Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. Journal of Molecular Endocrinology. 32: 397-414. PMID 15072547 DOI: 10.1677/jme.0.0320397  0.01
2004 Cohen PA. A decade of professional experience with globalization 2004 International Symposium On Technology and Society, Istas '04 Globalizing Technological Education. 1-8.  0.01
2003 Cohen PA. China unbound: Evolving perspectives on the Chinese past China Unbound: Evolving Perspectives On the Chinese Past. 1-226. DOI: 10.4324/9780203403297  0.01
2002 Cohen PA. Intrabodies. Targeting scFv expression to eukaryotic intracellular compartments Methods in Molecular Biology (Clifton, N.J.). 178: 367-378. PMID 11968506  0.01
2002 Kalifa G, Cohen PA, Hamidou A. The intervertebral disk: A landmark for spinal diseases in children European Radiology. 12: 660-665. PMID 11870483  0.01
2002 Cohen PA. Halogenated anthraquinones from the rare southern Illinois lichen Lasallia papulosa Lichenologist. 34: 521-525. DOI: 10.1006/lich.2002.0419  0.01
2001 Hendricson WD, Cohen PA. Oral health care in the 21st century: Implications for dental and medical education Academic Medicine. 76: 1181-1206. PMID 11739041  0.01
Hide low-probability matches.